BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 37605009)

  • 1. A novel agonist of 4-1BB costimulatory receptor shows therapeutic efficacy against a tobacco carcinogen-induced lung cancer.
    Gulen AE; Rudraboina R; Tarique M; Ulker V; Shirwan H; Yolcu ES
    Cancer Immunol Immunother; 2023 Nov; 72(11):3567-3579. PubMed ID: 37605009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of recombinant human trimeric CD137L (4-1BBL). Cross-linking is essential to its T cell co-stimulation activity.
    Rabu C; Quéméner A; Jacques Y; Echasserieau K; Vusio P; Lang F
    J Biol Chem; 2005 Dec; 280(50):41472-81. PubMed ID: 16204238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel Form of 4-1BBL Prevents Cancer Development via Nonspecific Activation of CD4
    Barsoumian HB; Batra L; Shrestha P; Bowen WS; Zhao H; Egilmez NK; Gomez-Gutierrez JG; Yolcu ES; Shirwan H
    Cancer Res; 2019 Feb; 79(4):783-794. PubMed ID: 30770367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineered soluble, trimerized 4-1BBL variants as potent immunomodulatory agents.
    Battin C; De Sousa Linhares A; Leitner J; Grossmann A; Lupinek D; Izadi S; Castilho A; Waidhofer-Söllner P; Grabmeier-Pfistershammer K; Stritzker J; Steinberger P
    Cancer Immunol Immunother; 2023 Sep; 72(9):3029-3043. PubMed ID: 37310433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel form of 4-1BBL has better immunomodulatory activity than an agonistic anti-4-1BB Ab without Ab-associated severe toxicity.
    Schabowsky RH; Elpek KG; Madireddi S; Sharma RK; Yolcu ES; Bandura-Morgan L; Miller R; MacLeod KJ; Mittler RS; Shirwan H
    Vaccine; 2009 Dec; 28(2):512-22. PubMed ID: 19836479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 4-1BB ligand as an effective multifunctional immunomodulator and antigen delivery vehicle for the development of therapeutic cancer vaccines.
    Sharma RK; Schabowsky RH; Srivastava AK; Elpek KG; Madireddi S; Zhao H; Zhong Z; Miller RW; Macleod KJ; Yolcu ES; Shirwan H
    Cancer Res; 2010 May; 70(10):3945-54. PubMed ID: 20406989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel adenovirus expressing human 4-1BB ligand enhances antitumor immunity.
    Yoshida H; Katayose Y; Unno M; Suzuki M; Kodama H; Takemura S; Asano R; Hayashi H; Yamamoto K; Matsuno S; Kudo T
    Cancer Immunol Immunother; 2003 Feb; 52(2):97-106. PubMed ID: 12594573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The systemic administration of Ig-4-1BB ligand in combination with IL-12 gene transfer eradicates hepatic colon carcinoma.
    Xu DP; Sauter BV; Huang TG; Meseck M; Woo SL; Chen SH
    Gene Ther; 2005 Oct; 12(20):1526-33. PubMed ID: 15973445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble CD137 (4-1BB) ligand is released following leukocyte activation and is found in sera of patients with hematological malignancies.
    Salih HR; Schmetzer HM; Burke C; Starling GC; Dunn R; Pelka-Fleischer R; Nuessler V; Kiener PA
    J Immunol; 2001 Oct; 167(7):4059-66. PubMed ID: 11564827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of 4-1BB and 4-1BBL in thymocytes during thymus regeneration.
    Kim YM; Kim HK; Kim HJ; Lee HW; Ju SA; Choi BK; Kwon BS; Kim BS; Kim JB; Lim YT; Yoon S
    Exp Mol Med; 2009 Dec; 41(12):896-911. PubMed ID: 19745604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and function of 4-1BB and 4-1BB ligand on murine dendritic cells.
    Futagawa T; Akiba H; Kodama T; Takeda K; Hosoda Y; Yagita H; Okumura K
    Int Immunol; 2002 Mar; 14(3):275-86. PubMed ID: 11867564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ex vivo expansion of CD4+CD25+FoxP3+ T regulatory cells based on synergy between IL-2 and 4-1BB signaling.
    Elpek KG; Yolcu ES; Franke DD; Lacelle C; Schabowsky RH; Shirwan H
    J Immunol; 2007 Dec; 179(11):7295-304. PubMed ID: 18025172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structure of the m4-1BB/4-1BBL complex reveals an unusual dimeric ligand that undergoes structural changes upon 4-1BB receptor binding.
    Bitra A; Doukov T; Destito G; Croft M; Zajonc DM
    J Biol Chem; 2019 Feb; 294(6):1831-1845. PubMed ID: 30545939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 4-1BB ligand-mediated costimulation of human T cells induces CD4 and CD8 T cell expansion, cytokine production, and the development of cytolytic effector function.
    Wen T; Bukczynski J; Watts TH
    J Immunol; 2002 May; 168(10):4897-906. PubMed ID: 11994439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous 4-1BB ligand plays a critical role in protection from influenza-induced disease.
    Lin GH; Sedgmen BJ; Moraes TJ; Snell LM; Topham DJ; Watts TH
    J Immunol; 2009 Jan; 182(2):934-47. PubMed ID: 19124736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD28-independent, TRAF2-dependent costimulation of resting T cells by 4-1BB ligand.
    Saoulli K; Lee SY; Cannons JL; Yeh WC; Santana A; Goldstein MD; Bangia N; DeBenedette MA; Mak TW; Choi Y; Watts TH
    J Exp Med; 1998 Jun; 187(11):1849-62. PubMed ID: 9607925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structures of the human 4-1BB receptor bound to its ligand 4-1BBL reveal covalent receptor dimerization as a potential signaling amplifier.
    Bitra A; Doukov T; Croft M; Zajonc DM
    J Biol Chem; 2018 Jun; 293(26):9958-9969. PubMed ID: 29720398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 4-1BB ligand activates bystander dendritic cells to enhance immunization in trans.
    Macdonald DC; Hotblack A; Akbar S; Britton G; Collins MK; Rosenberg WC
    J Immunol; 2014 Nov; 193(10):5056-64. PubMed ID: 25305314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SA-4-1BBL and monophosphoryl lipid A constitute an efficacious combination adjuvant for cancer vaccines.
    Srivastava AK; Dinc G; Sharma RK; Yolcu ES; Zhao H; Shirwan H
    Cancer Res; 2014 Nov; 74(22):6441-51. PubMed ID: 25252915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibroblast activation protein-targeted-4-1BB ligand agonist amplifies effector functions of intratumoral T cells in human cancer.
    Trüb M; Uhlenbrock F; Claus C; Herzig P; Thelen M; Karanikas V; Bacac M; Amann M; Albrecht R; Ferrara-Koller C; Thommen D; Rothschield S; Savic Prince S; Mertz KD; Cathomas G; Rosenberg R; Heinzelmann-Schwarz V; Wiese M; Lardinois D; Umana P; Klein C; Laubli H; Kashyap AS; Zippelius A
    J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32616554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.